James McMahon

5.7k total citations
91 papers, 2.4k citations indexed

About

James McMahon is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, James McMahon has authored 91 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Infectious Diseases, 41 papers in Virology and 26 papers in Epidemiology. Recurrent topics in James McMahon's work include HIV/AIDS Research and Interventions (42 papers), HIV Research and Treatment (40 papers) and HIV/AIDS drug development and treatment (26 papers). James McMahon is often cited by papers focused on HIV/AIDS Research and Interventions (42 papers), HIV Research and Treatment (40 papers) and HIV/AIDS drug development and treatment (26 papers). James McMahon collaborates with scholars based in Australia, United States and Denmark. James McMahon's co-authors include Sharon R. Lewin, Julian Elliott, Michael R. Jordan, Silvia Bertagnolio, Jillian S. Y. Lau, Celia W. Campagnoni, T Pribýl, Tsuyoshi Kashima, Kathy Kampf and Vance Handley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

James McMahon

87 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James McMahon Australia 28 1.3k 917 612 482 345 91 2.4k
Ricardo Sobhie Diaz Brazil 30 2.0k 1.5× 1.9k 2.1× 672 1.1× 346 0.7× 292 0.8× 159 3.1k
Annemarie M. J. Wensing Netherlands 29 1.9k 1.5× 1.6k 1.8× 578 0.9× 262 0.5× 226 0.7× 99 2.6k
Philip Cunningham Australia 35 1.6k 1.2× 1.2k 1.3× 1.5k 2.5× 359 0.7× 360 1.0× 113 3.5k
Mark A. Marzinke United States 30 2.1k 1.6× 972 1.1× 1.1k 1.8× 268 0.6× 110 0.3× 171 3.1k
Kenneth Rich United States 32 1.9k 1.4× 1.2k 1.3× 869 1.4× 352 0.7× 414 1.2× 80 3.3k
Édouard Tuaillon France 30 1.3k 1.0× 547 0.6× 1.3k 2.2× 317 0.7× 410 1.2× 147 2.9k
Francesca Ceccherini‐Silberstein Italy 33 2.5k 1.9× 2.1k 2.3× 881 1.4× 754 1.6× 221 0.6× 196 3.5k
Sibyl P. M. Geelen Netherlands 28 1.0k 0.8× 664 0.7× 553 0.9× 166 0.3× 262 0.8× 59 1.9k
Carl W. Dieffenbach United States 34 1.9k 1.4× 1.0k 1.1× 1.2k 2.0× 1.3k 2.7× 1.1k 3.1× 60 4.9k
Sheldon Morris United States 33 1.3k 1.0× 802 0.9× 1.2k 1.9× 634 1.3× 188 0.5× 102 2.8k

Countries citing papers authored by James McMahon

Since Specialization
Citations

This map shows the geographic impact of James McMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McMahon more than expected).

Fields of papers citing papers by James McMahon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James McMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McMahon. The network helps show where James McMahon may publish in the future.

Co-authorship network of co-authors of James McMahon

This figure shows the co-authorship network connecting the top 25 collaborators of James McMahon. A scholar is included among the top collaborators of James McMahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James McMahon. James McMahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Youry, Ajantha Rhodes, Carolin Tumpach, et al.. (2025). Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir. Journal of Virology. 99(3). e0167624–e0167624.
2.
Griffiths, Paul, et al.. (2025). Impact of Late HIV Diagnosis on Costs of Care in a Public Health Care Setting. AIDS Research and Human Retroviruses. 41(6). 286–291.
3.
Griffin, David, et al.. (2025). Solid organ transplantation in people with HIV : Outcomes, obstacles and opportunities. HIV Medicine. 26(11). 1632–1645. 1 indexed citations
4.
Griffin, David, C. Orla Morrissey, Sharon R. Lewin, et al.. (2024). Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial. Trials. 25(1). 485–485. 1 indexed citations
5.
Angrisano, Fiona, Emily M. Eriksson, Shuning Zheng, et al.. (2023). Serological assays to measure dimeric IgA antibodies in SARS‐CoV‐2 infections. Immunology and Cell Biology. 101(9). 857–866.
6.
Chiu, Chris, James McMahon, Steven G. Deeks, et al.. (2023). Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy. Frontiers in Immunology. 14. 1123342–1123342. 14 indexed citations
7.
Tan, Hyon‐Xhi, Kathleen M. Wragg, Hannah G. Kelly, et al.. (2022). Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil. The Journal of Immunology. 208(10). 2267–2271. 5 indexed citations
8.
McMahon, James, et al.. (2022). The Impact of the COVID-19 Pandemic on People with HIV in Victoria, Australia: 1 Year Later. AIDS Research and Human Retroviruses. 38(11). 875–877. 3 indexed citations
9.
10.
Zerbato, Jennifer M., Georges Khoury, Wei Zhao, et al.. (2021). Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency. EBioMedicine. 65. 103241–103241. 25 indexed citations
11.
McMahon, James, et al.. (2021). The Impact of the COVID-19 Pandemic on People Living with HIV in Victoria, Australia. AIDS Research and Human Retroviruses. 37(4). 322–328. 28 indexed citations
12.
13.
Hartley, Gemma E., Emily S.J. Edwards, Pei M. Aui, et al.. (2020). Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence. Science Immunology. 5(54). 180 indexed citations
14.
Lau, Jillian S. Y., Miranda Z. Smith, Brent Allan, et al.. (2019). Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies. AIDS Research and Human Retroviruses. 36(4). 260–267. 33 indexed citations
15.
Siefried, Krista J., Limin Mao, Lucette A. Cysique, et al.. (2017). Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy. AIDS. 32(1). 35–48. 61 indexed citations
16.
Medland, Nicholas, Eric P. F. Chow, James McMahon, et al.. (2017). Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015. PLoS ONE. 12(5). e0177634–e0177634. 16 indexed citations
17.
O’Brien, D., Tim Spelman, Jane Greig, et al.. (2016). Risk factors for mortality during antiretroviral therapy in older populations in resource‐limited settings. Journal of the International AIDS Society. 19(1). 20665–20665. 10 indexed citations
18.
McMahon, James, Anand Manoharan, Christine Wanke, et al.. (2013). Pharmacy and Self-Report Adherence Measures to Predict Virological Outcomes for Patients on Free Antiretroviral Therapy in Tamil Nadu, India. AIDS and Behavior. 17(6). 2253–2259. 17 indexed citations
19.
McMahon, James, Anand Manoharan, Christine Wanke, et al.. (2013). Targets for intervention to improve virological outcomes for patients receiving free antiretroviral therapy in Tamil Nadu, India. AIDS Care. 26(5). 559–566. 3 indexed citations
20.
McMahon, James, Michael R. Jordan, Kent R. Kelley, et al.. (2011). Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment Monitoring. Clinical Infectious Diseases. 52(4). 493–506. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Sobhie Diaz Breakdown of academic impact, for papers by Annemarie M. J. Wensing Breakdown of academic impact, for papers by Philip Cunningham Breakdown of academic impact, for papers by Mark A. Marzinke Breakdown of academic impact, for papers by Kenneth Rich Breakdown of academic impact, for papers by Édouard Tuaillon Breakdown of academic impact, for papers by Francesca Ceccherini‐Silberstein Breakdown of academic impact, for papers by Sibyl P. M. Geelen Breakdown of academic impact, for papers by Carl W. Dieffenbach Breakdown of academic impact, for papers by Sheldon Morris
Rankless by CCL
2026